183 related articles for article (PubMed ID: 15160338)
41. [Clinical study of TS-1 therapy for inoperable and recurrent gastric cancer].
Moriwaki T; Hyodo I; Nishina T; Kajiwara T; Tsuzuki T; Hirao K; Nakauchi M; Nasu J; Hirasaki S; Endo H; Masumoto T; Tanimizu M; Kubo Y; Kurita A
Gan To Kagaku Ryoho; 2003 Apr; 30(4):489-94. PubMed ID: 12722679
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
[TBL] [Abstract][Full Text] [Related]
43. Pilot study of S-1 in patients with disseminated gastric cancer.
Kitamura Y; Hayashi K; Sasagawa T; Oguma H; Takasaki K
Drugs Exp Clin Res; 2003; 29(3):125-30. PubMed ID: 14708458
[TBL] [Abstract][Full Text] [Related]
44. Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
Nomura T; Murakami R; Toya R; Teshima K; Nakahara A; Hirai T; Hiraki A; Nakayama H; Yoshitake Y; Ota K; Obayashi T; Yamashita Y; Oya N; Shinohara M
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1347-52. PubMed ID: 19628343
[TBL] [Abstract][Full Text] [Related]
45. [Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer].
Yumine K; Kawahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():189-92. PubMed ID: 16898000
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study.
Akaza H; Ikemoto I; Namiki M; Usami M; Kobayashi M; Fujimoto H; Tsukamoto T; Naito S
Oncology; 2010; 78(5-6):323-8. PubMed ID: 20699624
[TBL] [Abstract][Full Text] [Related]
47. [Late phase II study of S-1 in patients with advanced head and neck cancer].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
[TBL] [Abstract][Full Text] [Related]
48. Phase II trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperable biliary tract cancer.
Oh SY; Lee GW; Kim HG; Kim TH; Kim HJ; Kang JH
Chemotherapy; 2008; 54(6):479-84. PubMed ID: 18832821
[TBL] [Abstract][Full Text] [Related]
49. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
[TBL] [Abstract][Full Text] [Related]
50. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
51. Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.
Ajani JA; Faust J; Ikeda K; Yao JC; Anbe H; Carr KL; Houghton M; Urrea P
J Clin Oncol; 2005 Oct; 23(28):6957-65. PubMed ID: 16145066
[TBL] [Abstract][Full Text] [Related]
52. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors.
Peters GJ; Noordhuis P; Van Kuilenburg AB; Schornagel JH; Gall H; Turner SL; Swart MS; Voorn D; Van Gennip AH; Wanders J; Holwerda U; Smid K; Giaccone G; Fumoleau P; Van Groeningen CJ
Cancer Chemother Pharmacol; 2003 Jul; 52(1):1-12. PubMed ID: 12739060
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.
Borghaei H; Millenson M; Schilder R; Alden M; Rogatko A; Wang H; Padavic-Shaller K; Smith MR
Cancer; 2004 Nov; 101(9):2034-41. PubMed ID: 15455357
[TBL] [Abstract][Full Text] [Related]
55. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
56. Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis.
Uehara K; Maeda A; Sakamoto E; Hiramatsu K; Takeuchi E; Sakaguchi K; Tojima Y; Takahashi Y; Ebata T; Nagino M
Ann Surg Oncol; 2013 Feb; 20(2):475-81. PubMed ID: 22965575
[TBL] [Abstract][Full Text] [Related]
57. [Efficacy and safety of novel oral fluoropyrimidine anticancer drug, TS-1 for advanced and recurrent gastric cancer patients].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1297-301. PubMed ID: 14518409
[TBL] [Abstract][Full Text] [Related]
58. [A case report of rectal cancer with liver and pulmonary metastases responding to TS-1].
Nishimura G; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1453-6. PubMed ID: 11681257
[TBL] [Abstract][Full Text] [Related]
59. A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.
Saek T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Aoyama H; Ota J; Noguchi S; Taguchi T
Breast Cancer; 2004; 11(2):194-202. PubMed ID: 15550867
[TBL] [Abstract][Full Text] [Related]
60. Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer.
Wada M; Yamamoto M; Ryuge S; Nagashima Y; Hayashi N; Maki S; Otani S; Katono K; Takakura A; Yanaihara T; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Masuda N
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1005-11. PubMed ID: 22160350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]